EarningsQ2 2025 Earnings Report

Axsome Therapeutics (AXSM) Q2 2025 Earnings Report

1 Followers

MX:AXSM Q2 2025 EPS Results

Actual EPS-$17.82

Consensus EPS-$19.38

Beat/MissBeat by +$1.56

One Year Ago EPS-$30.68

Actual Revenue$2.76B

Expected Revenue$2.54B

Beat/MissBeat by +$220.91M

YoY Revenue Growth+72.13%

QuarterQ2 2025

Date08/04/2025

TimeBefore Open

Conference CallMonday, August 4, 2025

MX:AXSM Upcoming Earnings

Axsome Therapeutics's next earnings date is estimated for November 2, 2026, based on past reporting schedules.

MX:AXSM Q2 2025 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 02, 2026	2026 (Q3)	-10.60 / -	-17.272	―
Aug 10, 2026	2026 (Q2)	-16.39 / -18.19	-17.823	-2.06% (-0.37)
May 04, 2026	2026 (Q1)	-15.51 / -23.15	-22.417	-3.28% (-0.73)
Feb 23, 2026	2025 (Q4)	-12.75 / -10.29	-28.296	63.64% (+18.01)
Nov 03, 2025	2025 (Q3)	-15.82 / -17.27	-24.621	29.85% (+7.35)
Aug 04, 2025	2025 (Q2)	-19.38 / -17.82	-30.685	41.92% (+12.86)
May 05, 2025	2025 (Q1)	-24.82 / -22.42	-26.459	15.28% (+4.04)
Feb 18, 2025	2024 (Q4)	-18.39 / -28.30	-38.218	25.96% (+9.92)
Nov 12, 2024	2024 (Q3)	-25.41 / -24.62	-24.254	-1.52% (-0.37)
Aug 05, 2024	2024 (Q2)	-24.02 / -30.68	-28.296	-8.44% (-2.39)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed